These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 7175242)

  • 21. Oral contraceptive use and risk of cancer--response.
    Gierisch JM; Myers ER
    Cancer Epidemiol Biomarkers Prev; 2014 Apr; 23(4):677-8. PubMed ID: 24636973
    [No Abstract]   [Full Text] [Related]  

  • 22. [Oral contraceptives give long-lasting protection against ovarian cancer. Use of oral contraceptives can explain reduced incidence of ovarian cancer in Sweden].
    Milsom I; Odlind V
    Lakartidningen; 2008 Mar 5-11; 105(10):715-6. PubMed ID: 18422235
    [No Abstract]   [Full Text] [Related]  

  • 23. The possible role of female sex hormones in milk from pregnant cows in the development of breast, ovarian and corpus uteri cancers.
    Ganmaa D; Sato A
    Med Hypotheses; 2005; 65(6):1028-37. PubMed ID: 16125328
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Why are reproductive cancers more common in nulliparous women?
    Gleicher N
    Reprod Biomed Online; 2013 May; 26(5):416-9. PubMed ID: 23518034
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Use of oral contraceptives and risk of cancer].
    Bjørge T; Engeland A
    Tidsskr Nor Laegeforen; 2002 Aug; 122(18):1788-90. PubMed ID: 12362690
    [No Abstract]   [Full Text] [Related]  

  • 26. [Incidence and mortality of gynaecological cancers in Guadeloupe (French West Indies)].
    Kadhel P; Janky E; Multigner L
    Bull Cancer; 2009 Feb; 96(2):157-64. PubMed ID: 19258222
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Challenges for the current oral hormonal contraception when applied to women with increased risk for ovarian and breast malignancies].
    Usunova I
    Akush Ginekol (Sofiia); 2008; 47 Suppl 2():46-7. PubMed ID: 19504708
    [No Abstract]   [Full Text] [Related]  

  • 28. Oral contraceptive use and risk of breast cancer among women with a family history of breast cancer: a prospective cohort study.
    Silvera SA; Miller AB; Rohan TE
    Cancer Causes Control; 2005 Nov; 16(9):1059-63. PubMed ID: 16184471
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oral contraceptive use and risk of cancer--letter.
    Weiss NS
    Cancer Epidemiol Biomarkers Prev; 2014 Apr; 23(4):676. PubMed ID: 24636972
    [No Abstract]   [Full Text] [Related]  

  • 30. Oral contraceptives and the risk of death from breast cancer.
    Wingo PA; Austin H; Marchbanks PA; Whiteman MK; Hsia J; Mandel MG; Peterson HB; Ory HW
    Obstet Gynecol; 2007 Oct; 110(4):793-800. PubMed ID: 17906011
    [TBL] [Abstract][Full Text] [Related]  

  • 31. "We are on the threshold of an era when breast cancer ... can be prevented".
    Pike M
    Oncology (Williston Park); 1991 May; 5(5):14, 16, 21-2. PubMed ID: 1831996
    [No Abstract]   [Full Text] [Related]  

  • 32. A current perspective on genetic testing for breast and ovarian cancer: the oral contraceptive decision.
    Friedenson B
    MedGenMed; 2001 Nov; 3(6):2. PubMed ID: 11965197
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Oral contraception and risk of cancer. Epidemiological aspects of breast and gynecological cancers].
    Plu-Bureau G
    Rev Prat; 1995 Dec; 45(19):2441-4. PubMed ID: 8571057
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oral contraceptives and the risk of breast cancer.
    Grant EC
    N Engl J Med; 2002 Oct; 347(18):1448-9; author reply 1448-9. PubMed ID: 12418035
    [No Abstract]   [Full Text] [Related]  

  • 35. [Female genital cancer in Africa. Incidence and regional differences].
    Huber A
    Wien Med Wochenschr; 1965 Sep; 115(38):777-80. PubMed ID: 5893639
    [No Abstract]   [Full Text] [Related]  

  • 36. Oral contraceptives and ovarian cancer: an update, 1998-2004.
    La Vecchia C
    Eur J Cancer Prev; 2006 Apr; 15(2):117-24. PubMed ID: 16523008
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protection against endometrial carcinoma by combination-product oral contraceptives.
    Evrard JR
    JAMA; 1982 Aug; 248(6):647-8. PubMed ID: 7097914
    [No Abstract]   [Full Text] [Related]  

  • 38. Review of epidemiological evidence for reproductive and hormonal factors in relation to the risk of epithelial ovarian malignancies.
    Riman T; Nilsson S; Persson IR
    Acta Obstet Gynecol Scand; 2004 Sep; 83(9):783-95. PubMed ID: 15315588
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Malignant tumors of the ovary. Biological and epidemiological behavior].
    Mossetti C; Campagnoli C; Gilli V
    Minerva Ginecol; 1978 Dec; 30(12):1111-22. PubMed ID: 740328
    [No Abstract]   [Full Text] [Related]  

  • 40. Risk of breast cancer associated with short-term use of oral contraceptives.
    Folger SG; Marchbanks PA; McDonald JA; Bernstein L; Ursin G; Berlin JA; Daling JR; Norman SA; Strom BL; Weiss LK; Simon MS; Burkman RT; Malone KE; Spirtas R
    Cancer Causes Control; 2007 Mar; 18(2):189-98. PubMed ID: 17216547
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.